Abstract
Background Careful selection of patients for carotid stenting is necessary. We suggest that patients with a shaggy aorta syndrome may have a higher risk of perioperative embolic complications.
Methods The study is a subanalysis of the SIBERIA Trial. We included 72 patients undergoing transfemoral carotid artery stenting. All patients had an MRI DWI and a clinical neurological examination two days before and on the second and 30th days after the intervention.
Results 46 patients had shaggy aorta syndrome. Intraoperative embolisms were recorded in 82.6% and 46.1% of patients with and without shaggy aorta syndrome, respectively (p=0.001). New asymptomatic ischemic brain lesions in the postoperative period occurred in 78.3% and in 26.9% of patients with and without shaggy aorta syndrome, respectively (p=0.000). 3 (6.5%) cases of stroke within 30 days after the procedure were observed only in patients with shaggy aorta syndrome. Shaggy aorta syndrome (OR 5.54 [1.83:16.7], p=0.001) and aortic arch ulceration (OR 6.67 [1.19: 37.3], p = 0.02) were independently associated with cerebral embolism. Shaggy aorta syndrome (OR 9.77 [3.14-30.37], p=0.000) and aortic arch ulceration (OR 12.9 [2.3: 72.8], p = 0.003) were independently associated with ipsilateral new asymptomatic ischemic brain lesions.
Conclusions Shaggy aorta syndrome and aortic arch ulceration significantly increase the odds of intraoperative embolism and new asymptomatic ischemic brain lesions. Carotid endarterectomy or transcervical carotid stent should be selected in the presence of aortic ulceration.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov Identifier: NCT03488199
Funding Statement
This study was funded by the Russian Science Foundation, grant №21-15-00091
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Meshalkin National Medical Research Center Ethics Committee, protocol number 7 dated October 26, 2017
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Bugurov S. savr.doctor{at}mail.ru
Saaya S. s_saaya{at}meshalkin.ru
Gostev A. a_gostev{at}meshalkin.ru
Cheban A. cheban_a{at}meshalkin.ru
Ignatenko P. p_ignatenko{at}meshalkin.ru
Karpenko A. a_karpenko{at}meshalkin.ru
Declarations
Funding: this study was supported by the Russian Science Foundation, grant №21-15-00091
Conflicts of interest: the authors declare no conflicts of interest
Ethical approval: ethics committee approval was obtained, and a written informed consent was obtained from all participants before data collection
Data Availability
All data produced in the present work are contained in the manuscript
Abbreviations
- CAS
- carotid artery stenting
- CTA
- computed tomography angiography
- TIA
- transient ischemic attack
- ICA
- the internal carotid arteries
- MCA
- the middle cerebral artery
- TCD
- transcranial Doppler sonography
